New research raises concerns about safety of higher-THC medicinal cannabis products in Australia
New Monash University research has found that more than half of all adverse events reported to Australia's medicines regulator involving medicinal cannabis were linked to higher-THC products, with psychiatric disorders the most commonly reported adverse reactions.
ORIGINAL SOURCE →via Medical Xpress
ADVERTISEMENT
⚡ STAY AHEAD
Events like this, convergence-verified across 689 sources, land in your inbox every Sunday. Free.
GET THE SUNDAY BRIEFING →RELATED · AU
- [CONFLICT] Royal Australian Air Force announces Exercise Pitch Black for July-August 2026
- [CONFLICT] Australian North set to be appointed as England selector
- [CONFLICT] Almost $4bn more for Victoria’s contentious Suburban Rail Loop to be included in federal budget
- [CONFLICT] Women linked to IS fighters charged with slavery after landing in Australia
- [CONFLICT] Candlelight vigils held across Australia for 5-year-old Indigenous girl found dead
- [CONFLICT] Australia's superb fairywren caught in a rain shower: why the most iridescent bird on the continent has no real waterpro…